English
中文
HOME
ABOUT US
COMPANY PROFILE
ENTERPRISE VISION
JOIN US
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
MOST RECOMMENDED
QUALITY & COMPLIANCE
NEWS
COMPANY NEWS
INDUSTRY NEWS
SENOVA STATEMENT!!!
CONTACT US
Home >
NEWS
NEWS
COMPANY NEWS
INDUSTRY NEWS
SENOVA STATEMENT!!!
In warning letters, FDA tells 8 companies to stop selling illicit eye drugs
Eight companies are finding themselves in hot water for allegedly churning out illicit eye drugs, the FDA said Tuesday. The drugs are unapproved and illegally marketed, the FDA said, which is especially risky considering that medications administered throu..
2023-09-15
PHARMA Novo Nordisk posts 'best-case scenario' cardio outcomes data for star obesity drug Wegovy
Novo Nordisk has been riding the momentum of weight loss drug Wegovy ever since it stormed onto the market in 2021, creating widespread hype and even some supply shortfalls. But, now, a cardio outcomes trial could seriously change the game for the burgeoning..
2023-08-10
Eli Lilly's tirzepatide aces 2 more late-stage obesity trials as FDA decision nears
Also known as Mounjaro in its approved type 2 diabetes indication, tirzepatide helped participants across two trials—SURMOUNT-3 and SURMOUNT-4—lose up to 26.6% of their body weight, Lilly said Thursday. Tirzepatide met all primary endpoints across both..
2023-08-10
Molnupiravir FDA Approval Status
Molnupiravir (EIDD-2801/MK-4482) is an investigational, orally bioavailable form of a potent ribonucleoside analog in development for the treatment of COVID-19.1.Molnupiravir works as an antiviral agent by inhibiting the replication of the SARS-CoV-2 virus, th..
2021-10-25
COVID-19 tracker: CureVac sees hope for vaccine despite trial flop; AZ jab highly protective against death in older adults
CureVac said its vaccine, only 48% effective in late-stage clinical trials, could still pose a "strong public health value."Two doses of AstraZeneca's vaccine prevent roughly 94% of deaths in older people, according to Public Health England.The w..
2021-07-02
COVID-19 tracker: Azar pegs 6.4M Pfizer doses for mid-December delivery; GAVI welcomes AZ shot data
The U.S. expects to distribute 6.4 million doses of Pfizer and BioNTech's shot by mid-December, should the vaccine pass the FDA's bar, Department of Health and Human Services secretary Alex Azar said. Meanwhile, the World Health Organization's vacc..
2020-11-26
First
Previous
current 1/6 page
total 36 records
per page 6 Article
1
2
3
Next
End
PRODUCTS
API
ADVANCED INTERMEDIATES
PEPTIDES
FINE CHEMICALS
OTHERS
SERVICE
DMF/CMC/ SMF PREPARATION
PRE-AUDIT/AUDIT INTERPRETATION
PHARMACEUTICAL DOCUMENT TRANSLATION
eCTD DMF SUBMISSION
NEWS
COMPANY NEWS
INDUSTRY NEWS
SENOVA STATEMENT!!!
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: Room2012, Tower A of Shangmei International Building, 1355# Liuxian Avenue, Nanshan Dist., Shenzhen, China 518055 Tel:
+86-0755-8670 3119
QQ: 530953397 Email:
info@senovatech.com